Pascale Boissel
Vermogen: 1 881 $ op 31-05-2026
Vermogen: 1 881 $ op 31-05-2026
Pascale Boissel currently works at Sartorius Stedim Biotech SA, as Independent Non-Executive Director from 2019 and Innate Pharma SA, as Independent Member-Supervisory Board from 2020.
Ms. Boissel also formerly worked at BioAster, as Director-Finance & Administration & Deputy CEO from 2012 to 2016, ENYO Pharma SA, as CFO, Director-Finance & Administration from 2017 to 2018, Poxel SA, as Independent Director, QIAGEN Marseille SA, as Chief Financial Officer & Head-Media Relations from 2009 to 2012, and Novadiscovery SA, as Chief Financial Officer from 2017 to 2021.
Ms. Boissel received her undergraduate degree and Masters Business Admin degree from École des Hautes Études Commerciales de Paris.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-03-2026 | 1.000 ( 0% ) | 1 881 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| SARTORIUS STEDIM BIOTECH | Directeur/Bestuurslid | 26-03-2019 |
| INNATE PHARMA | Directeur/Bestuurslid | 19-05-2020 |
| Bedrijven | Functie | Einde |
|---|---|---|
Novadiscovery SAS
Novadiscovery SAS Information Technology ServicesTechnology Services Operates as a health technology company | Financieel Directeur/CFO | 01-01-2021 |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Financieel Directeur/CFO | 01-05-2018 |
BioAster
BioAster Miscellaneous Commercial ServicesCommercial Services Operates as a research institute | Financieel Directeur/CFO | 01-12-2016 |
| QIAGEN MARSEILLE | Financieel Directeur/CFO | 01-01-2012 |
| POXEL | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 8 |
|---|---|
Poxel SA
Poxel SA Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company, focuses on the development of novel treatments for serious chronic diseases | Health Technology |
Innate Pharma SA
Innate Pharma SA Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies that harness the immune system to improve cancer treatment and clinical outcomes | Health Technology |
École des Hautes Études Commerciales de Paris
École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sartorius Stedim Biotech SA
Sartorius Stedim Biotech SA Medical SpecialtiesHealth Technology Manufactures and supplies biopharmaceutical products and medical equipment | Health Technology |
QIAGEN Marseille SA
QIAGEN Marseille SA Miscellaneous Commercial ServicesCommercial Services Develops and markets molecular diagnostic tests for cancer | Commercial Services |
BioAster
BioAster Miscellaneous Commercial ServicesCommercial Services Operates as a research institute | Commercial Services |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Novadiscovery SAS
Novadiscovery SAS Information Technology ServicesTechnology Services Operates as a health technology company | Technology Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau